Shares in the NYSE-listed company dropped 2.8% at market open following the earnings, possibly a reflection of 2025 guidance.

Abbott stock reversed early losses Wednesday on its strong sales outlook for 2025 and a bullish performance from its diabetes ...

For 2025, Abbott forecast organic sales growth of between 7.5% and 8.5%, as well as adjusted earnings per share of $5.05 to $5.25. Analysts expect $5.16 a share on $42 billion in sales.

Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

Johnson & Johnson , fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular , reported fourth-quarter ...

Abbott Laboratories on Wednesday forecast annual profit in line with Wall Street estimates, as it expects elevated ...

Pennsylvania has several neighbors with legal adult-use sales, including Delaware, Maryland, New Jersey, New York and Ohio.

They began 2024 saying "I do" to each other at a ritzy wedding ceremony. Back then, a glamorous Scottsdale couple hardly ...

Last year was another strong one for the stock market. The S&P 500 was up 23%, while the Nasdaq Composite rallied nearly 29%. In particular, the real estate investment trust (REIT) sector has fallen ...

Varex Imaging Corporation's stock has declined 25% over the past year, and revenues decreased year-over-year basis in the ...

After reviewing the scientific evidence, the agency has decided 20 ZYN nicotine pouch products can legally be sold in the US.